All-Cause and Cause-Specific Mortality Associated with Bariatric Surgery: A Review Ted D. AdamsTapan S. MehtaSteven C. Hunt Lipid and Metabolic Effects of Gastrointestinal Surgery (R. Cohen, Section Editor) 26 October 2015 Article: 74
Novel Approaches to Targeting Visceral and Hepatic Adiposities in HIV-Associated Lipodystrophy Phyllis C. Tien Clinical Trials and Their Interpretations (J. Kizer, Section Editor) 22 October 2015 Article: 73
Role of Ezetimibe in Lipid-Lowering and Cardiovascular Disease Prevention Bryan A. SmithCharmaine WrightMichael Davidson Clinical Trials and Their Interpretations (J. Kizer, Section Editor) 21 October 2015 Article: 72
Advances in the Detection and Monitoring of Atrial Fibrillation for Patients with Cryptogenic Ischemic Stroke Rajbeer Singh SanghaRichard Bernstein Cardiovascular Disease and Stroke (S. Prabhakaran) 21 October 2015 Article: 71
MicroRNA Biomarkers for Coronary Artery Disease? Dorothee KaudewitzAnna ZampetakiManuel Mayr Genetics (A. Marian, Section Editor) Open access 21 October 2015 Article: 70
Statin Intolerance: the Clinician’s Perspective Tomáš StulcRichard CeškaAntonio M. Gotto Jr. Statin Drugs (B. Wiggins, Section Editor) Open access 21 October 2015 Article: 69
Fibrinolysis for Acute Care of Pulmonary Embolism in the Intermediate Risk Patient Guy MeyerBenjamin PlanquetteOlivier Sanchez Clinical Trials and Their Interpretations (J. Kizer, Section Editor) 20 October 2015 Article: 68
Surgical Strategies for Management of Mitral Regurgitation: Recent Evidence from Randomized Controlled Trials George Tolis JrThoralf M. Sundt III Clinical Trials and Their Interpretations (J. Kizer, Section Editor) 20 October 2015 Article: 67
Paroxysmal Atrial Fibrillation in Cryptogenic Stroke: an Overlooked Explanation? Cen ZhangScott E. Kasner Clinical Trials and Their Interpretations (J. Kizer, Section Editor) 20 October 2015 Article: 66
